The Urology Department is responsible for the medical and surgical treatment of pathologies associated with the male and female urinary tract and the male genitalia.
Its activities are essentially diagnosis and treatment and the monitoring of cancerous and non-cancerous conditions affecting the prostate, kidneys, bladder and male genitalia.
As our work is principally oncological in nature, we operate a strongly multidisciplinary approach to the treatment of all cancerous conditions associated with the genitourinary system.
Our team therefore works in close and constant collaboration with the Institut Bordet’s medical oncologists, radiotherapists, radiologists, nuclear medicine specialists and anatomopathologists.
The Institut Bordet Urology Department treats :
- prostate conditions:
- diagnosis of all prostate diseases
- treatment of benign prostate hypertrophia
- refinement (diagnosis) of prostate cancers via different examinations including biopsies conducted on an out-patient basis and under local anaesthesia
- hormone treatments
- surgical treatments mainly via robotic surgery
- focused ultrasound prostate treatment.
- Bladder conditions:
- treatment of incontinence problems (surgery, rehabilitation, urodynamic testing, etc)
- treatment of common bladder infections (for example, cystitis)
- diagnosis and treatment of bladder polyps (via fluorescent light)
- diagnosis and surgical treatment of malignant bladder tumours (cancers) with bladder reconstruction in cases of total organ ablation.
- Kidney and ureteral conditions:
- diagnosis and treatment of infectious diseases of the kidney (pyelonephritis, for example), renal calculi (kidney stones), etc.
- diagnosis and treatment of benign kidney tumours (cysts, for example)
- diagnosis and treatment of malignant tumours (cancers) of the kidney
- robotic surgery.
- Conditions affecting the male genitalia:
- diagnosis and treatment of cancerous and non-cancerous tumours of the penis and testicles
- laser treatment and sentinel node technique.
The Institut Bordet Urology Department is at the leading edge of fusion imaging, targeting and focused prostate cancer treatments (MRI – ultrasound – high frequency ultrasound).
Thanks to advances in medical imaging, in particular magnetic resonance imaging of the prostate, it is now possible to define suspect areas within the prostate. The Institut Bordet is the first centre to offer fusion imaging software. This software makes it possible to achieve very high precision guidance of the biopsies needed to characterise cancer. This fusion imaging is then exported in order to carry out focused treatment of the affected zones using high-energy ultrasound, thus allowing non-invasive, transrectal treatment of prostate cancer.
Head of Department
Dr A. Peltier
Dr G. Assenmacher
Prof. T. Roumeguère
Dr L. Demaeyer
Dr K. Mirzoyan
M. Requena Castro
External Validation of a Multiparametric Magnetic Resonance Imaging-based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Authors : Diamand R, Ploussard G, Roumiguié M, Oderda M, Benamran D, Fiard G, Quackels T, Assenmacher G, Simone G, van Damme J, Malavaud B, Iselin C, Descotes JL, Roche JB, Peltier A, Roumeguère T, Albisinni S
Year : 2020
Journal : Eur Urol
Laparoscopic transperitoneal pudendal nerve and artery release for pudendal entrapment syndrome.
Authors : Bollens R, Mjaess G, Sarkis J, Chemaly AK, Nemr E, Daher K, Semaan A, Chebel JA, Absil F, Aoun F
Year : 2020
Journal : Surg Endosc
Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassifications.
Authors : Diamand R, Ploussard G, Roumiguié M, Malavaud B, Oderda M, Gontero P, Fourcade A, Fournier G, Benamran D, Iselin C, Fiard G, Descotes JL, Peltier A, Simone G, Roche JB, Roumeguère T, Albisinni S
Year : 2020
Journal : Urol Oncol
Can the success with immunotherapy in metastatic urothelial bladder carcinoma be replicated in the neoadjuvant setting?
Authors : Aoun F, Mjaess G, Nemr E, Albisinni S, Roumeguere T
Year : 2020
Journal : Immunotherapy
Volume : 12
Pages : 1209-1212
Validation externe du nomogramme basé sur l’imagerie par résonance magnétique prédisant le risque d’effraction extra-capsulaire et d’invasion des vésicules séminales chez des patients opérés de prostatectomie radicale.
Authors : Diamand R, Ploussard G, Roumiguié M, Oderda M, Benamran D, Fiard G, Quackels T, Assenmacher G, Simone G, van Damme J, Malavaud B, Iselin C, Descotes J, Roche J, Peltier A, Roumeguère T, Albisinni S
Year : 2020
Journal : Prog Urol
Volume : 30
Pages : 774-775